Alix Ventures
Early-stage life sciences venture capital firm focused on seed and Series A investments in innovative biotechnology companies. Specializes in company formation and early-stage company building.
Website
https://www.alix.vcLocation
San Francisco, USA
Founded
2016
AUM
$150M+
Investment Range
$500K - $5M
Focus
biotech-focused
Fund Stages
seed, series-a
Investment Thesis
Alix Ventures focuses on the earliest stages of company formation in life sciences, working closely with scientists and entrepreneurs to build companies from inception. They specialize in identifying breakthrough science and providing the capital and operational support needed to translate discoveries into viable companies.
Team
Partners / Managing Directors (Health & Bio Focus)
- Christoph Westphal, MD, PhD - Managing Partner
- Noubar Afeyan, PhD - Venture Partner
Other Key Team Members
- Investment team with deep biotech operating experience
Focus Areas
- Early-Stage Therapeutics
- Platform Technologies
- Precision Medicine
- Genetic Medicines
- Novel Drug Discovery
- Biotechnology
Notable Exits
- Portfolio companies advancing through clinical development
- Multiple successful follow-on financings